Clinical Trial Update: Proof of Concept (Bone Resorption/Bone Mineral Density) Study (0429-005) [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial evaluating bone resorption and bone mineral density in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Investigational compound (unspecified)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Post-Menopausal Osteoporosis | Phase 2 | Status: COMPLETED